Bilsland D, Crombie I K, Ferguson J
Department of Dermatology, Ninewells Hospital and Medical School, Dundee, U.K.
Br J Dermatol. 1994 Aug;131(2):209-14. doi: 10.1111/j.1365-2133.1994.tb08493.x.
In the management of photosensitivity dermatitis/actinic reticuloid syndrome (PD/AR) (syn. chronic actinic dermatitis), a chronic and often severe photodermatosis, there has been concern that patients may be predisposed to the development of lymphoreticular malignancy. A follow-up study of 231 patients with PD/AR who had been investigated at the Photobiology Unit, Ninewells Hospital, Dundee, between 1971 and 1991, was undertaken to determine (i) the incidence and type of malignancies (ii) the causes of any deaths. This information was obtained from three sources: (a) National Cancer Registry data, (b) death certificates, (c) when possible or practical, by casenote review. Thirty-eight malignancies had occurred (in 37 of the 231 patients). Although six of the 38 malignancies were lymphoma registrations, it emerged from a review of casenotes, pathology reports and death certificates that five of the six were incorrect: two were labelled 'mycosis fungoides' prior to diagnosis of PD/AR; a case of dermatopathic lymphadenopathy was initially reported as Hodgkin's disease; clerical errors had occurred in two cases. The remaining case was a true B-cell lymphoma. The occurrence of one lymphoreticular malignancy is not significantly different from the number expected in a normal population (0.96), when applying 5-year age-, sex-, and site-specific incidence rates to the cumulative patient years of risk [standardized incidence ratio 1.04 (95% CI 0.03-5.79)]. There was also no significant increase in the risk of non-lymphoma malignancies in the PD/AR subjects. Since diagnosis, 83 patients have died, the majority from cardiorespiratory or cerebrovascular diseases, or the reported malignancies, a pattern expected in an elderly population.(ABSTRACT TRUNCATED AT 250 WORDS)
在光敏性皮炎/光化性类网状细胞增多综合征(PD/AR)(同义词:慢性光化性皮炎)的管理中,这是一种慢性且通常严重的光皮肤病,人们一直担心患者可能易患淋巴网状恶性肿瘤。对1971年至1991年间在邓迪九井医院光生物学科接受检查的231例PD/AR患者进行了一项随访研究,以确定:(i)恶性肿瘤的发病率和类型;(ii)任何死亡原因。这些信息来自三个来源:(a)国家癌症登记数据;(b)死亡证明;(c)在可能或可行的情况下,通过病例记录回顾。已发生38例恶性肿瘤(231例患者中的37例)。尽管38例恶性肿瘤中有6例是淋巴瘤登记病例,但通过对病例记录、病理报告和死亡证明的回顾发现,其中5例是错误的:2例在PD/AR诊断前被标记为“蕈样肉芽肿”;1例皮肤性淋巴结病最初报告为霍奇金病;2例出现了文书错误。其余1例是真正的B细胞淋巴瘤。当将5年年龄、性别和部位特异性发病率应用于累积患者风险年数时,1例淋巴网状恶性肿瘤的发生与正常人群预期数量(0.96)无显著差异[标准化发病率为1.04(95%CI 0.03 - 5.79)]。PD/AR患者中非淋巴瘤恶性肿瘤的风险也没有显著增加。自诊断以来,83例患者死亡,大多数死于心肺或脑血管疾病,或报告的恶性肿瘤,这是老年人群中预期的模式。(摘要截短于250字)